New hope for Hard-to-Treat colorectal cancer: drug cocktail trial launches
NCT ID NCT04068610
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding new cancer drugs to standard chemotherapy and bevacizumab can better control metastatic microsatellite-stable colorectal cancer. About 61 adults with this advanced cancer will receive different treatment combinations. The goal is to find safer, more effective first-line therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MICROSATELLITE-STABLE COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Los Angeles, California, 90095, United States
-
Research Site
Sacramento, California, 95817, United States
-
Research Site
Ann Arbor, Michigan, 48109, United States
-
Research Site
Las Vegas, Nevada, 89169, United States
-
Research Site
New York, New York, 10065, United States
-
Research Site
Canton, Ohio, 44718, United States
-
Research Site
Providence, Rhode Island, 02903, United States
-
Research Site
Chattanooga, Tennessee, 37404, United States
-
Research Site
Nashville, Tennessee, 37203, United States
-
Research Site
Houston, Texas, 77030, United States
-
Research Site
Charlottesville, Virginia, 22908, United States
-
Research Site
Clayton, 3168, Australia
-
Research Site
Heidelberg, 3084, Australia
-
Research Site
Melbourne, 3000, Australia
-
Research Site
Toronto, Ontario, M5G 1X6, Canada
-
Research Site
Nantes, 44000, France
-
Research Site
Villejuif, 94805, France
-
Research Site
Barcelona, 08035, Spain
-
Research Site
Barcelona, 08916, Spain
-
Research Site
Madrid, 28027, Spain
-
Research Site
Madrid, 28046, Spain